Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Capital Reinvestment Ratio
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Capital Reinvestment Ratio of 5.05x as of September 2025, meaning it reinvests 5% of its operating cash flow (CN¥833.94K) in capital expenditures (CN¥4.21 Million). See 002907 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2024)
This chart tracks Chongqing Pharscin Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. Check 002907 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year Capital Reinvestment Ratio for Chongqing Pharscin Pharmaceutical Co Ltd from 2013 to 2024. For live market cap and broader valuation context, see Chongqing Pharscin Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥161.77 Million | CN¥16.15 Million | ▼ -76.4% |
| 2023 | 0.42x | CN¥219.34 Million | CN¥92.82 Million | ▼ -90.9% |
| 2022 | 4.65x | CN¥13.04 Million | CN¥60.62 Million | ▲ +579.7% |
| 2021 | 0.68x | CN¥82.85 Million | CN¥56.64 Million | ▲ +66.4% |
| 2020 | 0.41x | CN¥113.64 Million | CN¥46.69 Million | ▼ -58.1% |
| 2019 | 0.98x | CN¥65.92 Million | CN¥64.66 Million | ▼ -14.1% |
| 2018 | 1.14x | CN¥31.80 Million | CN¥36.30 Million | ▲ +121.8% |
| 2017 | 0.51x | CN¥81.34 Million | CN¥41.87 Million | ▲ +78.1% |
| 2016 | 0.29x | CN¥57.73 Million | CN¥16.69 Million | ▲ +18.0% |
| 2015 | 0.25x | CN¥66.10 Million | CN¥16.20 Million | ▼ -64.1% |
| 2014 | 0.68x | CN¥20.22 Million | CN¥13.79 Million | ▲ +69.3% |
| 2013 | 0.40x | CN¥47.34 Million | CN¥19.06 Million | — |